Benefits and harms of prostate cancer screening - predictions of the ONCOTYROL prostate cancer outcome and policy model

Main|Search|PHGKB

From From Genomics & Health Impact Scan Database

This database includes published scientific literature on evidence-based translation of genomic discoveries into improved health care and disease prevention that have a potential impact on population health.

---

• Benefits and harms of prostate cancer screening - predictions of the ONCOTYROL prostate cancer outcome and policy model.  
  Mühlberger Nikolai et al. BMC public health 2017 Jun 17(1) 596
• New blood test uses nanotechnology to predict aggressive prostate cancer accurately  
  Science Mag, June 9, 2017
• Epigenetic Signature: A New Player as Predictor of Clinically Significant Prostate Cancer (PCa) in Patients on Active Surveillance (AS).  
  Ferro Matteo et al. International journal of molecular sciences 2017 May 18(6)
• Biomarker Test Could Reduce Unnecessary Biopsies to Detect Prostate Cancer  
  NCI, June 9, 2017
• Genetics of Prostate Cancer (PDQ®) -Health Professional Version  
  PDQ Cancer Genetics Editorial Board, NCI, May 2017

more